TY  - JOUR
AU  - Navarro-Triviño, Francisco José
AU  - Galán-Gutiérrez, Manuel
AU  - Armario-Hita, José Carlos
AU  - Ruiz-Villaverde, Ricardo
AU  - Domínguez-Cruz, Javier
AU  - Pereyra-Rodriguez, Jose Juan
PY  - 2024
DO  - 10.1089/derm.2023.0220
SN  - 1710-3568 / 2162-5220)
UR  - https://hdl.handle.net/10668/28525
T2  - Dermatitis
AB  - Background: Hand-foot eczema (HFE) are special locations of dermatitis, which are often associated with atopic dermatitis (AD) and have a significant negative impact on the quality of life, demanding a clinically relevant improvement.Objectives: To...
LA  - en
PB  - Mary Ann Liebert, Inc Publishers
KW  - Dupilumab
KW  - Atopic Dermatitis
KW  - Hand Eczema
KW  - Foot Eczema
KW  - Real-world Evidence
KW  - Dermatitis, Atopic
KW  - Eczema
KW  - Hands
KW  - Feet
KW  - Antibodies, Monoclonal, Humanized
TI  - Real-world clinical experience of dupilumab in the treatment of chronic palmo-plantar eczema in patients with moderate-severe atopic dermatitis: 52-week follow-up
TY  - research article
VL  - 35
ER  -